Wed Sep 18 17:25:58 UTC 2024: ## Agenus Inc. Faces Class Action Lawsuit Over Misleading Statements

**NEW YORK, Sept. 18, 2024** – The Gross Law Firm has announced a class action lawsuit against Agenus Inc. (NASDAQ: AGEN), alleging the company made false and misleading statements regarding the effectiveness of its immuno-oncology products.

The lawsuit claims that Agenus overstated the effectiveness of its combination therapy of botensilimab and balstilimab, leading to inflated expectations for the drugs’ clinical results, regulatory approval, and commercial prospects.

Investors who purchased AGEN shares between January 23, 2023, and July 17, 2024, are encouraged to contact the Gross Law Firm regarding potential lead plaintiff appointment. The deadline to register for the class action is November 5, 2024.

The Gross Law Firm is a nationally recognized class action law firm specializing in representing investors who have suffered financial losses due to corporate misconduct.

This lawsuit comes after a period of scrutiny for Agenus, with investors expressing concern over the company’s financial performance and the effectiveness of its drugs.

Agenus has not yet issued a public statement on the lawsuit.

Read More